GENZ/PFE—LOL re Jami Rubin’s (GS) attempt to get PFE to comment on whether it’s pursuing GENZ: “With respect to your business development goals… could you comment on your interest in acquiring a biopharmaceutical company with a market cap between $18B and $20B?”
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”